Clinical Trials
6 trialsNCT01772719 2019-11-18
Overcoming Chemotherapy Resistance In Refractory Multiple Myeloma With Simvastatin and Zoledronic Acid
University of Louisville
Phase NA Terminated
NCT02971410 2018-07-02
Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Withdrawn
NCT01332617 2017-12-29
Phase II Study of Simvastatin for Relapsed/Refractory Myeloma
University of Louisville
Phase 2 Withdrawn
NCT00503763 2015-04-16
PSMMSS
Meir Medical Center
Phase 2 Withdrawn
NCT00281476 2011-11-01
The Effect of High Dose Simvastatine on Multiple Myeloma
Vejle Hospital
Phase 1/2 Completed
NCT00399867 2006-12-20
Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.
Ludwig-Maximilians - University of Munich
Phase 2 Completed